Evidence map›Paper›PMID 35621507›Full record

ArticleBioengineering (Basel, Switzerland)2022

A Deep Learning Approach for the Morphological Recognition of Reactive Lymphocytes in Patients with COVID-19 Infection.

José Rodellar, Kevin Barrera, Santiago Alférez, Laura Boldú, Javier Laguna, Angel Molina, Anna Merino

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

José RodellarDepartment of Mathematics, Barcelona Est Engineering School, Universitat Politècnica de Catalunya, 08019 Barcelona, Spain.ORCID 0000-0002-1514-7713
Kevin BarreraDepartment of Mathematics, Barcelona Est Engineering School, Universitat Politècnica de Catalunya, 08019 Barcelona, Spain.ORCID 0000-0002-1072-6142
Santiago AlférezSchool of Engineering, Science and Technology, Universidad del Rosario, Bogotá 111711, Colombia.ORCID 0000-0001-8661-1096
Laura BoldúBiomedical Diagnostic Center, Core Laboratory, Department of Biochemistry and Molecular Genetics, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-5162-3182
Javier LagunaBiomedical Diagnostic Center, Core Laboratory, Department of Biochemistry and Molecular Genetics, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-0777-6998
Angel MolinaBiomedical Diagnostic Center, Core Laboratory, Department of Biochemistry and Molecular Genetics, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-9584-3646
Anna MerinoBiomedical Diagnostic Center, Core Laboratory, Department of Biochemistry and Molecular Genetics, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-1889-8889
Hospital Clínic de Barcelona · ESUniversitat Politècnica de Catalunya · ESUniversidad del Rosario · CO

Funding

Ministry of Science and Innovation of Spain PID2019-104087RB-I00
6 · The paper itself

Abstract

Laboratory medicine plays a fundamental role in the detection, diagnosis and management of COVID-19 infection. Recent observations of the morphology of cells circulating in blood found the presence of particular reactive lymphocytes (COVID-19 RL) in some of the infected patients and demonstrated that it was an indicator of a better prognosis of the disease. Visual morphological analysis is time consuming, requires smear review by expert clinical pathologists, and is prone to subjectivity. This paper presents a convolutional neural network system designed for automatic recognition of COVID-19 RL. It is based on the Xception71 structure and is trained using images of blood cells from real infected patients. An experimental study is carried out with a group of 92 individuals. The input for the system is a set of images selected by the clinical pathologist from the blood smear of a patient. The output is the prediction whether the patient belongs to the group associated with better prognosis of the disease. A threshold is obtained for the classification system to predict that the smear belongs to this group. With this threshold, the experimental test shows excellent performance metrics: 98.3% sensitivity and precision, 97.1% specificity, and 97.8% accuracy. The system does not require costly calculations and can potentially be integrated into clinical practice to assist clinical pathologists in a more objective smear review for early prognosis.

Indexed as

blood cell imagescell morphologyconvolutional neural networksCOVID-19deep learningdiagnosisprognosisreactive lymphocytes

Identifiers

PMID35621507
PMCPMC9137554
OpenAlexW4281397442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.